D-0316 First Time in Patients Ascending Dose Study

Clinical trial NCT03452150 · COMPLETED

Trial details

NCT number: NCT03452150
Sponsor: InventisBio Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Non Small Cell Lung Cancer

Start date: 2018-01-03
Primary completion: 2020-08-28
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.